146 related articles for article (PubMed ID: 35975881)
1. A Water-Soluble Antimony-Rich Polyoxometalate with Broad-Spectrum Antitumor Activities.
Xiao HP; Hao YS; Li XX; Xu P; Huang MD; Zheng ST
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202210019. PubMed ID: 35975881
[TBL] [Abstract][Full Text] [Related]
2. Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.
Wang X; Wei S; Zhao C; Li X; Jin J; Shi X; Su Z; Li J; Wang J
J Biol Inorg Chem; 2022 Aug; 27(4-5):405-419. PubMed ID: 35713714
[TBL] [Abstract][Full Text] [Related]
3. Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.
Fu L; Gao H; Yan M; Li S; Li X; Dai Z; Liu S
Small; 2015 Jun; 11(24):2938-45. PubMed ID: 25721026
[TBL] [Abstract][Full Text] [Related]
4. Polyoxometalate-biomolecule conjugates: a new approach to create hybrid drugs for cancer therapeutics.
Yang HK; Cheng YX; Su MM; Xiao Y; Hu MB; Wang W; Wang Q
Bioorg Med Chem Lett; 2013 Mar; 23(5):1462-6. PubMed ID: 23337597
[TBL] [Abstract][Full Text] [Related]
5. Polyoxometalate Nanoparticles as a Potential Glioblastoma Therapeutic via Lipid-Mediated Cell Death.
Petronek MS; Allen BG; Luthe G; Stolwijk JM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897839
[TBL] [Abstract][Full Text] [Related]
6. Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.
Bijelic A; Aureliano M; Rompel A
Angew Chem Int Ed Engl; 2019 Mar; 58(10):2980-2999. PubMed ID: 29893459
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.
Cao H; Li C; Qi W; Meng X; Tian R; Qi Y; Yang W; Li J
PLoS One; 2017; 12(7):e0181018. PubMed ID: 28704559
[TBL] [Abstract][Full Text] [Related]
8. Polyoxometalate-based materials in extraction, and electrochemical and optical detection methods: A review.
Bagheri AR; Aramesh N; Chen J; Liu W; Shen W; Tang S; Lee HK
Anal Chim Acta; 2022 May; 1209():339509. PubMed ID: 35569843
[TBL] [Abstract][Full Text] [Related]
9. Two Polyoxometalate-Encapsulated Two-Fold Interpenetrating
Xin J; Pang H; Jin Z; Wu Q; Yu X; Ma H; Wang X; Tan L; Yang G
Inorg Chem; 2022 Oct; 61(40):16055-16063. PubMed ID: 36173134
[TBL] [Abstract][Full Text] [Related]
10. Folin-Ciocalteu Assay Inspired Polyoxometalate Nanoclusters as a Renal Clearable Agent for Non-Inflammatory Photothermal Cancer Therapy.
Zhou J; Zhao W; Miao Z; Wang J; Ma Y; Wu H; Sun T; Qian H; Zha Z
ACS Nano; 2020 Feb; 14(2):2126-2136. PubMed ID: 32027121
[TBL] [Abstract][Full Text] [Related]
11. All-inorganic networks and tetramer based on tin(II)-containing polyoxometalates: tuning structural and spectral properties with lone-pairs.
Zhao C; Glass EN; Chica B; Musaev DG; Sumliner JM; Dyer RB; Lian T; Hill CL
J Am Chem Soc; 2014 Aug; 136(34):12085-91. PubMed ID: 25076405
[TBL] [Abstract][Full Text] [Related]
12. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo.
Dong Z; Tan R; Cao J; Yang Y; Kong C; Du J; Zhu S; Zhang Y; Lu J; Huang B; Liu S
Eur J Med Chem; 2011 Jun; 46(6):2477-84. PubMed ID: 21481498
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing stoichiometry and stability of polyoxometalate - peptide complexes.
Greijer BH; Nestor G; Eriksson JE; Seisenbaeva GA; Kessler VG
Dalton Trans; 2022 Jun; 51(24):9511-9521. PubMed ID: 35695069
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanogels as nanocarriers of polyoxometalates for breast cancer therapies.
Pérez-Álvarez L; Ruiz-Rubio L; Artetxe B; Vivanco MD; Gutiérrez-Zorrilla JM; Vilas-Vilela JL
Carbohydr Polym; 2019 Jun; 213():159-167. PubMed ID: 30879655
[TBL] [Abstract][Full Text] [Related]
15. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
16. A Giant Heterometallic Polyoxometalate Nanocluster for Enhanced Brain-Targeted Glioma Therapy.
Song N; Lu M; Liu J; Lin M; Shangguan P; Wang J; Shi B; Zhao J
Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202319700. PubMed ID: 38197646
[TBL] [Abstract][Full Text] [Related]
17. Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.
El Moll H; Zhu W; Oldfield E; Rodriguez-Albelo LM; Mialane P; Marrot J; Vila N; Mbomekallé IM; Rivière E; Duboc C; Dolbecq A
Inorg Chem; 2012 Jul; 51(14):7921-31. PubMed ID: 22725619
[TBL] [Abstract][Full Text] [Related]
18. Polyoxometalate-polypeptide nanoassemblies as peroxidase surrogates with antibiofilm properties.
Soria-Carrera H; Atrián-Blasco E; de la Fuente JM; Mitchell SG; Martín-Rapún R
Nanoscale; 2022 Apr; 14(16):5999-6006. PubMed ID: 35348148
[TBL] [Abstract][Full Text] [Related]
19. Exploiting Interactions between Polyoxometalates and Proteins for Applications in (Bio)chemistry and Medicine.
Lentink S; Salazar Marcano DE; Moussawi MA; Parac-Vogt TN
Angew Chem Int Ed Engl; 2023 Aug; 62(31):e202303817. PubMed ID: 37098776
[TBL] [Abstract][Full Text] [Related]
20. Carbon-nanotube-assisted high loading and controlled release of polyoxometalates in biodegradable multilayer thin films.
Zhao Q; Feng X; Mei S; Jin Z
Nanotechnology; 2009 Mar; 20(10):105101. PubMed ID: 19417508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
